Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

SurgePays (SURG) EBITDA (2016 - 2025)

SurgePays has reported EBITDA over the past 16 years, most recently at -$12.8 million for Q4 2025.

  • For Q4 2025, EBITDA rose 36.21% year-over-year to -$12.8 million; the TTM value through Dec 2025 reached -$34.1 million, up 21.46%, while the annual FY2025 figure was -$34.1 million, 21.46% up from the prior year.
  • EBITDA for Q4 2025 was -$12.8 million at SurgePays, down from -$7.0 million in the prior quarter.
  • Over five years, EBITDA peaked at $7.1 million in Q3 2023 and troughed at -$20.1 million in Q4 2024.
  • A 5-year average of -$3.1 million and a median of -$1.0 million in 2022 define the central range for EBITDA.
  • Biggest five-year swings in EBITDA: skyrocketed 4001.1% in 2022 and later tumbled 2415.62% in 2024.
  • Year by year, EBITDA stood at -$90843.0 in 2021, then skyrocketed by 4001.1% to $3.5 million in 2022, then plummeted by 75.56% to $866249.0 in 2023, then tumbled by 2415.62% to -$20.1 million in 2024, then surged by 36.21% to -$12.8 million in 2025.
  • Business Quant data shows EBITDA for SURG at -$12.8 million in Q4 2025, -$7.0 million in Q3 2025, and -$6.8 million in Q2 2025.